Recurrent Glioblastoma: Where we stand

Sanjoy Roy; Debarshi Lahiri; Tapas Maji; Jaydip Biswas

doi:10.4103/2278-330X.175953

This article has been cited by
1	Spontaneous Glioblastoma Spheroid Infiltration of Early-Stage Cerebral Organoids Models Brain Tumor Invasion
	Bárbara da Silva,Ryan K. Mathew,Euan S. Polson,Jennifer Williams,Heiko Wurdak
	SLAS DISCOVERY: Advancing Life Sciences R&D. 2018; 23(8): 862
	[Pubmed] \| [DOI]

2	*Towards an advanced cell-based in vitro* glioma model system**
	Valeriia Mikhailova,Valeriia Gulaia,Vladlena Tiasto,Stanislav Rybtsov,Margarita Yatsunskaya,Alexander Kagansky
	AIMS Genetics. 2018; 5(2): 91
	[Pubmed] \| [DOI]

3	Localized targeted antiangiogenic drug delivery for glioblastoma
	Gregory D. Arnone,Abhiraj D. Bhimani,Tania Aguilar,Ankit I. Mehta
	Journal of Neuro-Oncology. 2018;
	[Pubmed] \| [DOI]

4	Bright Future for Novel Viral Glioblastoma Multiforme Therapy
	David McCarthy,Dallas Sheinberg,Ricardo J. Komotar,Robert M. Starke
	World Neurosurgery. 2018;
	[Pubmed] \| [DOI]

5	Molecular biology as a tool for the treatment of cancer
	Carla de Castro Sant’ Anna,Alberto Gomes Ferreira Junior,Paulo Soares,Fabricio Tuji,Eric Paschoal,Luiz Cláudio Chaves,Rommel Rodriguez Burbano
	Clinical and Experimental Medicine. 2018;
	[Pubmed] \| [DOI]

6	Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection
	C. Bastiancich,J. Bianco,K. Vanvarenberg,B. Ucakar,N. Joudiou,B. Gallez,G. Bastiat,F. Lagarce,V. Préat,F. Danhier
	Journal of Controlled Release. 2017;
	[Pubmed] \| [DOI]

7	A highly potent CDK4/6 inhibitor was rationally designed to overcome blood brain barrier in gliobastoma therapy
	Lei Yin,Heng Li,Wenjian Liu,Zhenglin Yao,Zhenzhen Cheng,Huabei Zhang,Hui Zou
	European Journal of Medicinal Chemistry. 2017;
	[Pubmed] \| [DOI]

8	Validation of an established prognostic score after re-irradiation of recurrent glioma
	Kerstin A. Kessel,Josefine Hesse,Christoph Straube,Claus Zimmer,Friederike Schmidt-Graf,Jürgen Schlegel,Bernhard Meyer,Stephanie E. Combs
	Acta Oncologica. 2017; : 1
	[Pubmed] \| [DOI]

9	Advances in Brain Tumor Surgery for Glioblastoma in Adults
	Montserrat Lara-Velazquez,Rawan Al-Kharboosh,Stephanie Jeanneret,Carla Vazquez-Ramos,Deependra Mahato,Daryoush Tavanaiepour,Gazanfar Rahmathulla,Alfredo Quinones-Hinojosa
	Brain Sciences. 2017; 7(12): 166
	[Pubmed] \| [DOI]

10	Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line
	Benxu Cheng,Liza Doreen Morales,Yonghong Zhang,Shizue Mito,Andrew Tsin,Salvatore V Pizzo
	PLOS ONE. 2017; 12(9): e0184324
	[Pubmed] \| [DOI]

11	Randomized Trial for Short-Term Radiation Therapy With Temozolomide in Elderly Patients With Glioblastoma
	David J. McCarthy,Ricardo J. Komotar,Robert M. Starke,E. Sander Connolly
	Neurosurgery. 2017; 81(3): N21
	[Pubmed] \| [DOI]

12	Identification of Driver Genes and Key Pathways of Glioblastoma Shows JNJ-7706621 as a Novel Antiglioblastoma Drug
	Sheng Zhong,Bo Wu,Xuechao Dong,Yujuan Han,Shanshan Jiang,Ying Zhang,Yang Bai,Sean X. Luo,Yong Chen,Huimao Zhang,Gang Zhao
	World Neurosurgery. 2017;
	[Pubmed] \| [DOI]

13	Recurrent glioblastoma: a single-institution experience with reirradiation and temozolomide
	Tejinder Kataria,Deepak Gupta,Ratika Gupta,Shikha Goyal,Shyam Singh Bisht,Trinanjan Basu,Ashu Abhishek,Kushal Narang,Susovan Banerjee
	Journal of Radiation Oncology. 2017;
	[Pubmed] \| [DOI]

14	Harnessing nanomedicine for therapeutic intervention in glioblastoma
	Anna Gutkin,Zvi R. Cohen,Dan Peer
	Expert Opinion on Drug Delivery. 2016; : 1
	[Pubmed] \| [DOI]